We previously found that SNF2, a gene encoding a transcription factor forming part of the SWI/SNF (switching/sucrose nonfermenting) chromatin-remodelling complex, is involved in lipid accumulation, because the snf2 disruptant of Saccharomyces cerevisiae has a higher lipid content. The present study was conducted to identify other factors that might further increase lipid accumulation in the snf2 disruptant. First, expression of LEU2 (a gene encoding β-isopropylmalate dehydrogenase), which was used to select transformed strains by complementation of the leucine axotroph, unexpectedly increased both growth and lipid accumulation, especially in the snf2 disruptant. The effect of LEU2 expression on growth and lipid accumulation could be reproduced by adding large amounts of leucine to the culture medium, indicating that the effect was not due to Leu2p (β-isopropylmalate dehydrogenase) itself, but rather to leucine biosynthesis. To increase lipid accumulation further, genes encoding the triacylglycerol biosynthetic enzymes diacylglycerol acyltransferase (DGA1) and phospholipid:diacylglycerol acyltransferase (LRO1) were overexpressed in the snf2 disruptant. Overexpression of DGA1 significantly increased lipid accumulation, especially in the snf2 disruptant, whereas LRO1 overexpression decreased lipid accumulation in the snf2 disruptant. Furthermore, the effect of overexpression of acyl-CoA synthase genes (FAA1, FAA2, FAA3 and FAA4) , which each supply a substrate for Dga1p (diacylglycerol acyltransferase), was investigated. Overexpression of FAA3, together with that of DGA1, did not further increase lipid accumulation in the snf2 disruptant, but did enhance lipid accumulation in the presence of exogenous fatty acids. Lastly, the total lipid content in the snf2 disruptant transformed with DGA1 and FAA3 overexpression vectors reached approx. 30 %, of which triacylglycerol was the most abundant lipid. Diacylglycerol acyltransferase activity was significantly increased in the snf2 disruptant strain overexpressing DGA1 as compared with the wild-type strain overexpressing DGA1; this higher activity may account for the prominent increase in lipid accumulation in the snf2 disruptant with DGA1 overexpression. The strains obtained have a lipid content that is high enough to act as a model of oleaginous yeast and they may be useful for the metabolic engineering of lipid production in yeast.
We previously found that SNF2, a gene encoding a transcription factor forming part of the SWI/SNF (switching/sucrose nonfermenting) chromatin-remodelling complex, is involved in lipid accumulation, because the snf2 disruptant of Saccharomyces cerevisiae has a higher lipid content. The present study was conducted to identify other factors that might further increase lipid accumulation in the snf2 disruptant. First, expression of LEU2 (a gene encoding β-isopropylmalate dehydrogenase), which was used to select transformed strains by complementation of the leucine axotroph, unexpectedly increased both growth and lipid accumulation, especially in the snf2 disruptant. The effect of LEU2 expression on growth and lipid accumulation could be reproduced by adding large amounts of leucine to the culture medium, indicating that the effect was not due to Leu2p (β-isopropylmalate dehydrogenase) itself, but rather to leucine biosynthesis. To increase lipid accumulation further, genes encoding the triacylglycerol biosynthetic enzymes diacylglycerol acyltransferase (DGA1) and phospholipid:diacylglycerol acyltransferase (LRO1) were overexpressed in the snf2 disruptant. Overexpression of DGA1 significantly increased lipid accumulation, especially in the snf2 disruptant, whereas LRO1 overexpression decreased lipid accumulation in the snf2 disruptant. Furthermore, the effect of overexpression of acyl-CoA synthase genes (FAA1, FAA2, FAA3 and FAA4), which each supply a substrate for Dga1p (diacylglycerol acyltransferase), was investigated. Overexpression of FAA3, together with that of DGA1, did not further increase lipid accumulation in the snf2 disruptant, but did enhance lipid accumulation in the presence of exogenous fatty acids. Lastly, the total lipid content in the snf2 disruptant transformed with DGA1 and FAA3 overexpression vectors reached approx. 30 %, of which triacylglycerol was the most abundant lipid. Diacylglycerol acyltransferase activity was significantly increased in the snf2 disruptant strain overexpressing DGA1 as compared with the wild-type strain overexpressing DGA1; this higher activity may account for the prominent increase in lipid accumulation in the snf2 disruptant with DGA1 overexpression. The strains obtained have a lipid content that is high enough to act as a model of oleaginous yeast and they may be useful for the metabolic engineering of lipid production in yeast.
INTRODUCTION
Baker's yeast (Saccharomyces cerevisiae) is a model organism for eukaryotes, and its lipid metabolism has been studied extensively [1, 2] . Previously, several important genes encoding storagelipid biosynthetic enzymes have been identified [3] [4] [5] [6] , and proteins associated with lipid particles have been elucidated [7] . Knowledge about storage-lipid biosynthesis in S. cerevisiae would make it possible to elucidate the molecular mechanisms of lipid accumulation. Nevertheless, S. cerevisiae does not accumulate storage lipids because only 5-7 % (per dry cell weight) of lipids are produced, whereas some oleaginous yeasts and fungi have 30 -50 % lipids. It is thus important to obtain S. cerevisiae strains with a higher lipid content that could be used as a model for studying lipid accumulation. Studies in oleaginous yeasts and fungi have revealed that several factors, such as ATP:citrate lyase and malic enzyme in the energy-production system [8, 9] , TAG (triacylglycerol) biosynthetic enzymes [10, 11] , and modulators of lipid body biogenesis [7, 12] , play important roles in lipid accumulation. Thus it could be also evaluated whether these factors affect lipid accumulation in S. cerevisiae.
With the aim of increasing lipid accumulation in S. cerevisiae, we recently identified genes that affect lipid accumulation by using transposon mutagenesis and found that the disruption of these genes did increase lipid content in this yeast [13] . The lipid content in these disruptants, however, was not high enough to represent a model of oleaginous yeasts, suggesting that other factors may be rate-limiting for further lipid accumulation. TAG-biosynthetic enzymes are possible candidates for such factors, and overexpression of these enzymes, such as DGAT (diacylglycerol acyltransferase) and phospholipid:diacyglycerol acyltransferase, has previously been reported to increase the lipid content in plants and yeasts [3,14 -16] . Therefore, to increase further the lipid content in S. cerevisiae, we have, in the present study, overexpressed TAG-biosynthetic enzymes in the snf2 disruptant, which has the highest lipid content among the previously characterized disruptants [13] . The snf2 mutant was initially isolated as a suppressor of sucrose fermentation [17] , and it has been shown that the SNF2 gene encodes a DNA-dependent ATPase that forms part of the SWI/SNF (switching/sucrose non-fermenting) chromatin-remodelling complex [18] . Although extensive studies have focused on transcriptional regulation by the SNF2 gene product, little is known about the effect of SNF2 gene expression on lipid accumulation. The results of the present study indicated that overexpression of DGA1 encoding yeast DGAT in the ∆snf2 disruptant induced greater lipid accumulation than its overexpression in the wild-type. In addition, leucine biosynthesis was unexpectedly found to increase lipid accumulation, especially in the ∆snf2 disruptant. Using these conditions, we constructed a yeast strain with a lipid content of approx. 30 %, which is high enough to represent a model of oleaginous yeasts.
EXPERIMENTAL Materials
Oleoyl-CoA, sn-1,2-dioleoylglycerol and Tergitol NP-40 were purchased from Sigma (St Louis, MO, U.S.A). [1- 14 C]OleoylCoA (58 mCi/mmol) was purchased from PerkinElmer Japan (Tokyo, Japan). Triton X-100 was purchased from Nacalai Tesque (Kyoto, Japan). Sodium ampicillin and LB (Luria-Bertani) medium were purchased from Wako Pure Chemical Industries (Osaka, Japan). Silica-gel 60 TLC plates were purchased from Merck (Darmstadt, Germany). Mouse anti-histidine monoclonal antibody and peroxidase-labelled sheep anti-mouse antibody were purchased from GE Healthcare UK Ltd. (Little Chalfont, Amersham, Bucks., U.K.). All other reagents were of analytical grade.
Strains and cultures
The S. cerevisiae BY4741 wild-type (Mat a leu2∆0 his3∆1 ura3∆0 met15∆0) and ∆snf2 disruptant (Mat a leu2∆0 his3∆1 ura3∆0 met15∆0 SNF2::kanMX) strains were purchased from Invitrogen (Carlsbad, CA, U.S.A.). The yeast cells were transformed by the lithium acetate method [19] using a transformation kit (Invitrogen). The yeast cells were aerobically grown at 30
• C in a synthetic medium as follows. The SD (synthetic defined) medium contained 0.17 % Bacto-yeast nitrogen base without amino acids and ammonium sulfate, 2 % (w/v) glucose, the required nutrients and 5 g/l ammonium sulfate. NLSD (nitrogen-limited SD) medium contained 0.17 % Bactoyeast nitrogen base without amino acids and ammonium sulfate, 2 % (w/v) glucose, the required nutrients and 1 g/l ammonium sulfate. Depending on the nutrient requirement of the strain, 20 µg/ml uracil, 60 µg/ml L-leucine, 20 µg/ml L-histidine and/or 20 µg/ml L-methionine were added as described in [20] . When the yeast cells were cultured with exogenous fatty acids, 0.25 % Tergitol NP-40 was added to the medium. Escherichia coli JM109 competent cells were purchased from Nippon Gene (Tokyo, Japan) and cultured in LB medium containing 50 µg/ml of ampicillin.
Cloning of TAG-biosynthetic-enzyme genes in yeast expression vectors
Genes encoding TAG biosynthetic enzymes in S. cerevisiae such as DGAT (DGA1), phospholipid:diacylglycerol acyltransferase (LRO1) and acyl-CoA synthase (FAA1, FAA2, FAA3, FAA4) were cloned by PCR into plasmid pL1091-5 or pL1177-2. PCR amplification was carried out by using S. cerevisiae genomic DNA as a template with KOD plus (Toyobo, Osaka, Japan) according to the manufacturer's protocol. The pL1091-5 vector contains the 2 µm replication origin, an ADH1 (alcohol dehydrogenase gene) promoter and a URA3 (orotidine 5 -phosphate decarboxylase gene) selection marker; and pL1177-2 is a LEU2 (β-isopropylmalate dehydrogenase gene) version of pL1091-5 [21] . To construct pL1091-5/DGA1-6 × His, DGA1 was initially cloned into pYES2/NT-C (Invitrogen) and the ORF (open reading frame) for DGA1 with a 6 × His coding region at the 5 end was excised as an HindIII-XbaI fragment for insertion into pL1091-5. The ORFs were then amplified with restriction sites to facilitate cloning into expression vectors. DGA1 was amplified by using the forward primer 5 -TAGAGCTCCGCAGAGGCATA-3 and the reverse primer 5 -AGTCTAGACAGCCCAAACAC-3 containing SacI and XbaI sites (underlined) respectively. To construct pL1091-5/DGA1-6 × His, another forward primer, 5 -GCGAATTCATGTCAGGAACA-3 , containing an EcoRI site, was used to avoid amplification of stop codons at the 5 end non-coding region of DGA1 by the former primer. The other TAG genes were cloned in the same way using the following primers: LRO1 forward, 5 -TAGGATCCATGGGCACACTGTTTC-3 , and reverse, 5 -GCTCTAGATTACATTGGGAAGGGC-3 (BamHI and XbaI sites respectively); FAA1 forward, 5 -GCGAGCTCAT-GGTTGCTCAATATACCG-3 , and reverse, 5 -ATGCGGCCGC-GATCCATTAAGACGAAC-3 (SacI and NotI sites respectively); FAA2 forward, 5 -CGTCTAGAATGGCCGCTCCAGATTA-3 , and reverse, 5 -TAGCGGCCGCTATGGATGTGCATAG-GG-3 (XbaI and NotI sites respectively); FAA3 forward, 5 -TAGAGCTCCAATGTCCGAACAACAC-3 , and reverse, 5 -GC-TCTAGAGGGAAGGTAATAAGCTTC-3 (SacI and XbaI sites respectively); FAA4 forward, 5 -CGTCTAGACGCATCAAAAT-GACCGA-3 , and reverse, 5 -TAGCGGCCGCGTGTTTATG-AAGGGCAG-3 (XbaI and NotI sites respectively). The PCR amplification products were verified by DNA sequencing.
Microscopy
A laser scanning confocal microscope (LSM 410; Carl Zeiss, Jena, Germany) with a 63× oil-immersion plan-apochromat objective lens (numerical aperture 1.4; Zeiss) was used for the imaging of Nile Red-stained yeast cells as described elsewhere [13, 22] .
Lipid analysis
The direct transmethylation of all fatty acid residues, including non-esterified ('free') fatty acids and esterified fatty acids in yeast cells was conducted using methanolic 10 % (v/v) HCl and methylene chloride, and the resultant fatty acid methyl esters were applied to a gas chromatograph (GC-17-A; Shimadzu, Kyoto, Japan) equipped with a TC-70 capillary column (GL Science, Tokyo, Japan) under temperature programming (180 -220
• C/min increments) as described elsewhere [13, 23] . Total fatty acids were quantified by using heptadecanoic acid methyl esters as the internal standards. The lipid content (%) of the yeast cells was usually expressed as the total fatty acid amount (mg) per dry cell weight (mg) × 100.
The total lipids were extracted by homogenizing the yeast cells with glass beads in chloroform/methanol (2:1, v/v) as described for the total lipid extraction of fungal cells [24] . The content of each lipid class, except for free sterol, was also expressed as the fatty acid amount included in the lipid class as described in [13] . Free sterol was quantified by densitometry of the TLC spots as described in [13] .
Immunoblotting
The homogenate from the yeast cells was subjected to SDS/ 12.5%-(w/v)-PAGE and blotted on to a PVDF membrane (Hybond-P; GE Healthcare). The membrane was blocked and incubated with a mouse anti-histidine monoclonal antibody (1:2000) . After washing, the membrane was incubated with peroxidase-labelled sheep anti-mouse antibody (1:2000) , and immune complexes were visualized using an enhancedchemiluminescence kit (ECL ® ; GE healthcare). The image was obtained with an image analyser (LAS-1000 plus; Fuji Photo Film Co., Tokyo, Japan).
Other analytical methods
Yeast cells suspended in Tris/HCl buffer, pH 7.4, containing 0.25 M sucrose and 1 mM EDTA, were homogenized with a Braun (Melsungen, Germany) homogenizer together with glass beads (diameter 0.45-0.50 mm) as described for the homogenization of fungal cells [25] . The homogenized cell suspensions were then centrifuged at 1500 g for 5 min to remove unbroken cells and nuclei, and the resultant supernatant was used as the homogenate. The DGAT assay was conducted in a reaction mixture containing 10 mM phosphate buffer, pH 7.0, 150 mM KCl, 3.4 µM (0.2 µCi/ml) [1-14 C]oleoyl-CoA, 1 mM 1,2-dioleoylglycerol, 0.1 % Triton X-100 and appropriate amounts of the homogenate as described elsewhere [25] . Protein was measured using Coomassie Blue dye reagent (Bio-Rad Laboratories, Herculus, CA, U.S.A.) [26] in the presence of 0.05 M NaOH.
RESULTS

Effects of LEU2 expression and addition of higher concentrations of leucine on lipid accumulation in the ∆snf2 disruptant
We intended to investigate whether vectors expressing the TAGbiosynthetic-enzyme genes could increase lipid accumulation in the ∆snf2 disruptant of S. cerevisiae. During the course of the experiment we found that transformation with pL1177-2 carrying no insert gene significantly increased dry cell weight and total fatty acids in the wild-type and ∆snf2 disruptant (Tables 1 and  2 ). The increase in dry cell weight and total fatty acids caused by transformation with pL1177-2 was much greater in the ∆snf2 disruptant than in the wild-type. In addition, the increase in total fatty acids in the ∆snf2 disruptant was significantly affected by the culture conditions. Culture in NLSD medium caused a greater increase in total fatty acids than culture in SD medium, and culture for 7 days accumulated more lipids than culture for 4 days. Transformation with pL1091-5, which contained URA3 as a selection marker instead of LEU2, did not affect dry cell 
Figure 1 Effect of leucine addition on growth and lipid content of the wildtype and ∆snf2 disruptant
The BY4741 wild-type strain (A) and ∆snf2 disruptant (B) were cultured at 30 • C in 50 ml of NLSD medium, to which required nutrients such as 20 µg/ml of histidine, 20 µg/ml of methionine or 20 µg/ml of uracil and the indicated concentration of leucine were added. Dry cell weight (᭹) and total fatty acids () were measured as described in the Experimental section. Lipid content (᭡) is expressed as total fatty acids (mg) per dry cell weight (mg) × 100. Results are means + − S.D. (n = 3) for a 50 ml sample of the culture.
weight or total fatty acids, indicating that expression of LEU2 was responsible for the increase in dry cell weight and total fatty acids.
To investigate further the effect of leucine metabolism on lipid accumulation, the wild-type and ∆snf2 disruptant were cultured in the presence of increasing concentrations of leucine. Concentrations of leucine higher than 250 µg/ml increased dry cell weight in the wild-type and ∆snf2 disruptant (Figure 1 ), and this increase was basically the same as that observed for the expression of LEU2 by pL1177-2. In addition, higher concentrations of leucine increased total fatty acids and lipid content in the ∆snf2 disruptant, whereas the increase in total fatty acids with higher concentrations of leucine was not significant in the wild-type. The increase in total fatty acids was induced at higher concentrations of leucine as compared with the increase in dry cell weight of the ∆snf2 disruptant, indicating that the exogenous leucine initially acted on cell growth and then increased lipid accumulation. These results indicated that leucine biosynthesis, rather than the presence of Leu2p, was crucial for the increase in cell growth and lipid accumulation. The addition of larger amounts of amino acids, including other required nutrients such as histidine, methionine or uracil, did not have such an effect (results not shown). The addition of 500 µg/ml phenylalanine, valine, isoleucine or tyrosine increased dry cell weight, but did not affect lipid accumulation (results not shown). These results suggest that the effects of leucine biosynthesis arise from mechanisms specific to leucine in which Snf2p is involved. On the basis of these observations, yeast transformation with pL1091-5 and pL1177-2 and yeast culture in NLSD medium for 7 days were subsequently used to investigate the effects of overexpression of the TAG-biosynthetic enzymes.
Effects of overexpression of TAG-biosynthetic enzymes on lipid accumulation in the ∆snf2 disruptant DGA1 or LRO1, both encoding enzymes crucial for TAG biosynthesis in yeast [27] [28] [29] , were overexpressed to increase lipid accumulation in the wild-type and the ∆snf2 disruptant. Table 3 shows that overexpression of DGA1 using a multicopy vector, pL1091-5, with a strong ADH1 promoter, had a much greater effect on total fatty acids and lipid content in the ∆snf2 disruptant than in the wild-type. These results indicate that DGAT is rate-limiting for the biosynthesis of storage lipids, especially in the disruptant. Overexpression of LRO1, by contrast, rather decreased total fatty acids and lipid content in the ∆snf2 disruptant, whereas a slight increase in total fatty acids and lipid content was observed on LRO1 overexpression in the wild-type.
As a next step to increase lipid accumulation in the ∆snf2 disruptant, we investigated the effect of overexpression of an acyl-CoA synthase gene, which would increase levels of one of the DGAT substrates, acyl-CoA. FAA1, FAA2, FAA3, and FAA4 encode acyl-CoA synthases with different substrate specificities [30] and Faa1p and Faa4p are involved in the fatty-acid-transport system [31] . It is not known, however, which gene products are involved in lipid biosynthesis, unlike those in the oleaginous yeast Candida lipolytica [32] . We found that overexpression of FAA1, FAA2, or FAA4 together with DGA1 decreased total fatty acids and lipid content in both wild-type and the ∆snf2 disruptant, Table 4 Effects of overexpression of DGA1 and a gene encoding acyl-CoA synthase on growth and lipid content of the wild-type and ∆snf2 disruptant The BY4741 wild-type or ∆snf2 disruptant strain transformed with pL1091-5 and pL1177-2 was cultured at 30 • C for 7 days in 50 ml of NLSD medium containing 20 µg/ml of histidine and 20 µg/ml of methionine. DGA1 was overexpressed from the pL1091-5 vector. FAA1, FAA2, FAA3 or FAA4 was overexpressed from the pL1177-2 vector. Results are means + − S.D. (n = 3) for a 50 ml sample of culture. Values in parentheses represent the ratio to that in the wild-type or ∆snf2 disruptant transformed with pL1091-5/DGA1 and pL1177-2. Lipid content is expressed as total fatty acids (mg) per dry cell weight (mg) × 100. whereas overexpression of FAA3 together with DGA1 increased or maintained the lipid content (Table 4) . On the basis of these results, it seems most likely that Faa3p is involved in lipid biosynthesis, but Faa1p, Faa2p and Faa4p are not. The limited effect of FAA3 overexpression on total fatty acid and lipid content suggests that the supply of acyl-CoA is not rate-limiting for TAG biosynthesis, especially in the ∆snf2 disruptant.
To confirm that the increase in growth and total fatty acids in the ∆snf2 disruptant transformed with pL1091-5/DGA1 and pL1177-2/FAA3 was due to the transformed vectors, we obtained colonies from the transformed strain that had subsequently lost these vectors. Loss of pL1177-2/FAA3 decreased the dry cell weight, but a high lipid content was kept, whereas loss of pL1091-5/DGA1 kept a high dry cell weight but resulted in a decreased lipid content (Table 5 ). Loss of both vectors altered the dry cell weight and lipid content to the levels seen in the ∆snf2 disruptant. These results confirmed that the increase in growth was due to LEU2 expression, and the increase in lipid content was due to DGA1 overexpression.
Characterization of the ∆snf2 disruptant transformed with pL1091-5/DGA1 and pL1177-2/FAA3
Because the ∆snf2 disruptant transformed with pL1091-5/DGA1 and pL1177-2/FAA3 was much more oleaginous than the wildtype, as judged by total fatty acid content, we conducted a more detailed characterization of this strain. On the basis of the total extracted lipids, including sterols, the lipid content reached nearly 30 % after the 7-day culture ( Table 6 ). The composition of the extracted lipids indicated that TAG accounted for a major lipid class (Table 7) , apparently due to overexpression of DGA1. Different sizes of lipid bodies were observed in the strain, but large lipid bodies with a diameter of approx. 2 µm, which were not observed in the untransformed ∆snf2 disruptant [13] , were detected ( Figure 2) .
In addition to the accumulation of endogenous lipids, the ∆snf2 disruptant transformed with pL1091-5/DGA1 and pL1177-2/FAA3 had the capacity to incorporate exogenous fatty acids into storage lipids (Table 8 ). The strain accumulated almost four times The BY4741 ∆snf2 disruptant transformed with pL1091-5/DGA1 and pL1177-2/FAA3 was plated on YPD (yeast extract/ peptone/dextrose) agar medium containing 10 g/l yeast extract, 20 g/l polypeptone, 20 g/l glucose and 20 g/l Bacto Agar ® . The procedure was repeated twice, and the colonies obtained were plated on SD agar medium with different nutrients to determine their nutrient requirement. Colonies requiring uracil and/or leucine were regarded as those with the loss of pL1091-5/DGA1 and/or pL1177-2/FAA3. These strains were cultured at 30 • C for 7 days in 50 ml of NLSD medium containing 20 µg/ml histidine, and 20 µg/ml methionine. When required, 20 µg/ml uracil and/or 60 µg/ml leucine was added to the medium. The vectors that were lost are underlined. Results are means + − S.D. (n = 3) for a 50 ml sample of culture. Values in parentheses represent the ratio to that in the ∆snf2 disruptant transformed with pL1091-5/DGA1 and pL1177-2/FAA3. Lipid content is expressed as total fatty acids (mg) per dry cell weight (mg) × 100.
Dry cell
Total fatty Lipid Strain weight (mg) acids (mg) content (%) acid incorporation, suggesting that Faa3p is also involved in the incorporation of exogenous fatty acids into storage lipids. In addition to oleic acid and linoleic acid, we investigated the incorporation of α-linolenic acid into each strain, which was almost the same as that for linoleic acid (results not shown).
To confirm that DGA1 overexpression induced an increase in DGAT activity, we measured DGAT activity in the homogenate of each strain (Table 9 ). It was evident that DGAT activity in the homogenate of the ∆snf2 disruptants transformed with pL1091-5/DGA1 was significantly increased, a finding that may explain the greater lipid accumulation in these strains. DGAT activity, however, remained very low in the homogenate of the wild-type with DGA1 overexpression. In addition, the homogenate of ∆snf2 Table 7 Major lipid classes in the ∆snf2 disruptant transformed with DGA1 and FAA3 overexpression vectors
The BY4741 ∆snf2 disruptant transformed with pL1091-5/DGA1 and pL1177-2/FAA3 was cultured at 30 • C for 4 or 7 days in 250 ml of NLSD medium containing 20 µg/ml of histidine, and 20 µg/ml of methionine. Lipids were extracted as described in the Experimental section. Major lipid classes were separated by TLC on silica-gel 60. Each lipid class except for free sterol is expressed as the amount of fatty acid present. Values in parentheses represent the percentage of total fatty acids. Free sterol was quantified by the densitometry of TLC spots as described in the Experimental section. Results are means + − S.D. (n = 3) for a 250 ml sample of culture. Each strain was cultured at 30 • C for 7 days in 50 ml of NLSD medium containing the required nutrients, 0.25 % Tergitol NP-40 and 2 g/l exogenous fatty acid, which was suspended in 200 µl of ethanol. When required, 20 µg/ml histidine, 20 µg/ml methionine, 20 µg/ml uracil and 60 µg/ml leucine were included in the medium. Incorporation of linoleic acid was calculated by dividing the amount of linoleic acid incorporated by the amount of linoleic acid added. Results are means + − S.D. (n = 3) for a 50 ml sample of culture. Values in parentheses represent the ratio to that in the wild-type (WT). Lipid content is expressed as total fatty acids (mg) per dry cell weight (mg) × 100. The homogenate from each strain, each of which was cultured at 30 • C for 4 or 7 days in 50 ml of NLSD medium containing required nutrients such as 20 µg/ml histidine, 20 µg/ml methionine, 20 µg/ml uracil and 60 µg/ml leucine, was obtained as described in the Experimental section. The DGAT activity in the homogenate (3-10 µg of protein) of each strain was assayed as described in the Experimental section. Results are means + − S.D. (n = 3).
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disruptants transformed with empty vectors had significantly higher DGAT activity than that of the wild-type, suggesting that DGAT was also activated by expression of LEU2 in the ∆snf2 disruptant. These results suggest that there are mechanisms to regulate the increase in DGAT activity, which may be abrogated in the ∆snf2 disruptant.
To determine whether the increase in DGAT activity in the ∆snf2 disruptants with DGA1 overexpression was due to increased levels of Dga1p, we expressed Dga1p with a hexahistidine (6 × His) tag by using pL1091-5/DGA1-6 × His for transformation of the ∆snf2 disruptant. The DGAT activity in the homogenate of the ∆snf2 disruptant transformed with pL1091-5/DGA1-6 × His was as high as that in the ∆snf2 disruptant transformed with pL1091-5/DGA1, whereas the DGAT activity remained very low in the homogenate of the wild-type. These results indicated that the attachment of hexahistidine did not affect the differential increase in DGAT activity between the ∆snf2 disruptant and the wild-type. Immunoblotting with antihexahistidine revealed that the homogenate of the wild-type and ∆snf2 disruptant transformed with pL1091-5/DGA1-6 × His had The cell homogenate was prepared from the wild-type (WT) and ∆snf2 disruptant transformed with pL1091-5/DGA1-6 × His and pL1177-2 (or pL1177-2/FAA3) that had been cultured for 4 (4d) or 7 days (7d). Each fraction (2 µg of protein) was subjected to SDS/12.5%-(w/v)-PAGE under reducing conditions, followed by immunoblotting with anti-hexahistidine monoclonal antibody as detailed in the Experimental section. Arrows indicate molecular-mass standards (Bio-Rad). DGAT activity in the homogenate of the ∆snf2 disruptant transformed with pL1091-5/DGA1-6xHis and pL1177-2 was 799 (4 days) or 354 (7 day) pmol/min per mg protein, whereas DGAT activity in the homogenate of the ∆snf2 disruptant transformed with pL1091-5/DGA1-6 × His and pL1177-2/FAA3 was 936 (4 days) or 388 (7 days) pmol/min per mg of protein. DGAT activity in the homogenate of the wild-type transformed with pL1091-5/DGA1-6xHis and pL1177-2 (or pL1177-2/FAA3) was less than 2 pmol/min per mg of protein.
similar amounts of Dga1p with a molecular mass of 50 kDa (Figure 3) . The differential in the amount of Dga1p was too low to explain the observed increase in DGAT activity, indicating that the increase in DGAT activity in the ∆snf2 disruptant with DGA1 overexpression was not due to greater amounts of Dga1p. Instead, Dga1p may be activated by some modification of Dga1p or by cofactors that interact with Dga1p.
DISCUSSION
Although the SNF2 gene, which encodes a subunit of the SWI/SNF chromatin-remodelling complex [18] , has been studied extensively from the aspect of transcriptional regulation, there have been very limited studies on its involvement in lipid metabolism. Kodaki et al. [33] previously reported that SNF2 is involved in the regulation of phospholipid synthesis enzymes that are repressed by inositol and choline in S. cerevisiae. Considering this with our previous observation that the ∆snf2 disruptant has a higher TAG content [13] , we assumed that SNF2 might regulate the biosynthesis of phospholipids and storage lipids such as TAG. The present study further demonstrated that overexpression of DGA1, a gene encoding one of the TAG-biosynthetic enzymes, significantly increased total fatty acids and lipid content in the ∆snf2 disruptant. Overexpression of DGA1 in the ∆snf2 disruptant significantly increased DGAT activity, which may contribute to the increase in lipid accumulation. Furthermore, we revealed that the higher DGAT activity in the ∆snf2 disruptant with DGA1 overexpression was not due to larger amounts of Dga1p. The observation suggests that DGAT is activated by post-translational modifications, as suggested previously [34, 35] . Alternatively, DGAT may be activated by other factors such as an increase in activator(s) or a decrease in inhibitor(s). Further studies using DGA1 overexpression in the ∆snf2 disruptant will address how the ∆snf2 disruption induces such a high increase in DGAT activity, which is not observed in the wild-type, and may reveal regulatory factors of DGAT.
The present study demonstrates that a non-oleaginous S. cerevisiae strain with 5-7 % lipid content can be changed to an oleaginous yeast with approx. 30 % lipid content by genetic modification. Although overexpression of a DGAT gene has previously been reported to increase the content of storage lipids [14] [15] [16] , such a high lipid content as presently obtained (30 %) had not been achieved. The ∆snf2 disruption together with specific culture conditions, such as leucine biosynthesis and nitrogen limitation, helped to increase lipid accumulation due to DGA1 overexpression.
Overexpression of LRO1, a gene encoding another important TAG-biosynthetic enzyme, somewhat decreased storage lipid content in the ∆snf2 disruptant, but slightly increased storage lipids in the wild-type. Because the ∆snf2 disruption is known to markedly decrease the expression of genes encoding the phospholipid-biosynthetic enzymes regulated by inositol and choline [33] , the phospholipid substrates of Lro1p may not be sufficient in the ∆snf2 disruptant. Alternatively, Lro1p may catalyse the reverse reaction to hydrolyse TAG in the ∆snf2 disruptant. Transacylation reactions of TAG have been observed in plants [36, 37] , and Lro1p may function to compensate for the decrease in phospholipids in the ∆snf2 disruptant [13] .
Two types of acyl-CoA synthase have been reported on the basis of work in C. lipolytica: one is involved in the synthesis of cellular lipids and the other is involved in the degradation of fatty acids [32] . Although it is known that S. cerevisiae has four acylCoA synthase genes whose gene products have different substrate specificities [30] , the physiological roles of these genes are not well understood. Among the four acyl-CoA synthase genes, overexpression of FAA2 or FAA4 significantly decreased lipid accumulation in the wild-type and ∆snf2 disruptant, and FAA1 overexpression decreased lipid accumulation, especially in the wild-type. The results are consistent with previous observations that Faa1p and Faa4p are involved in the import of exogenous fatty acids and their degradation [31] . Overexpression of FAA3 together with DGA1 significantly increased lipid accumulation in the wild-type and slightly decreased lipid accumulation in the ∆snf2 disruptant. In addition, overexpression of FAA3 increased lipid accumulation in the presence of exogenous fatty acids in the ∆snf2 disruptant. These results suggest that Faa3p plays the most important role in the biosynthesis of storage lipids from endogenous and exogenous fatty acids among the four different acyl-CoA synthases, although the possibility that Faa3p is also involved in degradation of the fatty acids cannot be excluded.
The present study revealed that expression of LEU2 enhanced growth and lipid accumulation, especially in the ∆snf2 disruptant. The addition of larger amounts of leucine induced similar effects on growth and lipid accumulation, indicating that leucine biosynthesis due to LEU2 expression was important in this effect rather than Leu2p itself. Because the addition of larger amounts of other amino acids did not have such an effect, we assume that leucine biosynthesis has a specific role in lipid accumulation in the ∆snf2 disruptant. It has been reported that leucine affects protein synthesis and autophagic proteolysis via the cell-growthregulating kinase TOR (target of rapamycin) [38] , which might also be involved in the effect of leucine on lipid accumulation. Although the nutritional regulation of leucine biosynthesis has been studied extensively [39] , its relationship to the synthesis of storage lipids has not been elucidated in yeast.
In conclusion, we found that factors such as DGA1 overexpression and leucine biosynthesis increased lipid accumulation especially in the ∆snf2 disruptant of S. cerevisiae. The total lipid content in the ∆snf2 disruptant transformed with pL1091-5/DGA1 and pL1177-2/FAA3 reached approx. 30 %; as a result, this strain can be used as a model of oleaginous yeasts. Studies using these strains may provide new insights into the mechanisms of lipid accumulation. In addition, these yeasts can be useful host organisms for the production of valuable lipids [40] . Further studies on genes involved in other glycerolipid syntheses [1, 2] , lipid degradation [41] , nutrient signalling [42, 43] and energyproduction systems [8, 9, 44] , in concert with the ∆snf2 disruption, may reveal other factors that regulate storage lipid biosynthesis.
